Zhang Yi, Pan Si-Yuan, Zhou Shu-Feng, Wang Xiao-Yan, Sun Nan, Zhu Pei-Li, Chu Zhu-Sheng, Yu Zhi-Ling, Ko Kam-Ming
Department of Pharmacology, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.
Drug Des Devel Ther. 2014 Sep 19;8:1429-39. doi: 10.2147/DDDT.S67518. eCollection 2014.
Schisandrin B (Sch B), a dibenzocyclooctadiene compound, is isolated from schisandrae fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil (SFO)-induced changes in hepatic and serum parameters in mice.
Institute of Cancer Research (ICR) mice were given a single oral dose of Sch B (0.125-2 g/kg) or SFO (0.3-5 g/kg). Serum alanine aminotransferase (ALT) activity, hepatic malondialdehyde, and triglyceride (TG) levels were measured at increasing time intervals within 6-120 hours postdosing.
Serum ALT activity was elevated by 60%, with maximum effect (E(max)) = 45.77 U/L and affinity (K(D)) = 1.25 g/kg at 48-96 hours following Sch B, but not SFO, treatment. Sch B and SFO treatments increased hepatic malondialdehyde level by 70% (E(max) =2.30 nmol/mg protein and K(D) =0.41 g/kg) and 22% (E(max) = 1.42 nmol/mg protein and K D = 2.56 g/kg) at 72 hours postdosing, respectively. Hepatic index was increased by 16%-60% (E max = 11.01, K(D) = 0.68 g/kg) and 8%-32% (E(max) = 9.88, K D = 4.47 g/kg) at 12-120 hours and 24-120 hours after the administration of Sch B and SFO, respectively. Hepatic TG level was increased by 40%-158% and 35%-85%, respectively, at 12-96 hours and 6-48 hours after Sch B and SFO treatment, respectively. The values of E max and K D for Sch B/SFO-induced increase in hepatic TG were estimated to be 22.94/15.02 μmol/g and 0.78/3.03 g/kg, respectively. Both Sch B and SFO increased serum TG (up to 427% and 123%, respectively), with the values of E(max) = 5.50/4.60 mmol/L and K D = 0.43/2.84 g/kg, respectively.
The findings indicated that Sch B/SFO-induced increases in serum/hepatic parameters occurred in a time-dependent manner, with the time of onset being serum TG level < hepatic TG level < hepatic index < serum ALT activity. However, the time of recovery of these parameters to normal values varied as follow: serum TG level < hepatic TG level and liver injury < hepatic index. The E max and affinity of Sch B on tissue/enzyme/receptor were larger than those of SFO.
五味子乙素(Sch B)是一种二苯并环辛二烯类化合物,从五味子果实(SF)中分离得到。本研究旨在比较Sch B和五味子油(SFO)诱导小鼠肝脏和血清参数变化的时间和剂量反应。
给癌症研究所(ICR)小鼠单次口服Sch B(0.125 - 2 g/kg)或SFO(0.3 - 5 g/kg)。在给药后6 - 120小时内,每隔一段时间测量血清丙氨酸氨基转移酶(ALT)活性、肝脏丙二醛和甘油三酯(TG)水平。
Sch B治疗后48 - 96小时,血清ALT活性升高60%,最大效应(E(max))= 45.77 U/L,亲和力(K(D))= 1.25 g/kg,而SFO治疗后未出现此情况。Sch B和SFO治疗分别在给药后72小时使肝脏丙二醛水平升高70%(E(max) = 2.30 nmol/mg蛋白质,K(D) = 0.41 g/kg)和22%(E(max) = 1.42 nmol/mg蛋白质,K D = 2.56 g/kg)。Sch B和SFO给药后12 - 120小时和24 - 120小时,肝脏指数分别升高16% - 60%(E max = 11.01,K(D) = 0.68 g/kg)和8% - 32%(E(max) = 9.88,K D = 4.47 g/kg)。Sch B和SFO治疗后12 - 96小时和6 - 48小时,肝脏TG水平分别升高40% - 158%和35% - 85%。Sch B/SFO诱导肝脏TG升高的E max和K D值估计分别为22.94/15.02 μmol/g和0.78/3.03 g/kg。Sch B和SFO均使血清TG升高(分别高达427%和123%),E(max)值分别为5.50/4.60 mmol/L和K D值分别为0.43/2.84 g/kg。
研究结果表明,Sch B/SFO诱导的血清/肝脏参数升高呈时间依赖性,起始时间为血清TG水平<肝脏TG水平<肝脏指数<血清ALT活性。然而,这些参数恢复至正常水平的时间如下:血清TG水平<肝脏TG水平和肝损伤<肝脏指数。Sch B对组织/酶/受体的E max和亲和力大于SFO。